Articles From: TCF Reports Quarterly Net Income of $53.1 Million, or 29 Cents Per Share, Up 8 Cents, or 38.1 Percent from the Second Quarter of 2013 to Moody's Corporation Reports Results for Second Quarter 2014


TCF Financial Corporation (NYSE:TCB): SECOND QUARTER HIGHLIGHTS - Revenue of $310.1 million, up 2.7 percent from the second quarter of 2013 - Loan and lease originations of $3.5 billion, up 8.6 percent from the second quarter of 2013 - Average deposits of $14.8 billion, up 4.6 percent from the second quarter of 2013 - Provision for credit losses of $9.9 million, down 69.6 percent from the second quarter of 2013 - Non-accrual loans and leases of $260.3 million, down 6.5 percent from the second quarter of 2013 - Return on average assets of 1.17 percent, up 27 basis points from the second quarter of 2013 - Return on average tangible common equity of 12.72 percent, up 282 basis points from the
Sign-up for TCF Reports Quarterly Net Income of $53.1 Million, or 29 Cents Per Share, Up 8 Cents, or 38.1 Percent from the Second Quarter of 2013 investment picks
2014/7/25
By Charles Passy, MarketWatch 1.
Sign-up for UPDATE: 10 things home-improvement stores won't tell you investment picks
2014/7/25
Indeed, with the high rates the store cards are charging, even a great introductory offer may matter little if you end up tapping the credit, says Odysseas Papadimitriou, chief executive of the personal finance website CardHub.com. "You can eat away those savings very quickly," he says.
Sign-up for UPDATE: 10 things home-improvement stores -2- investment picks
2014/7/25
By Jeff Reeves, MarketWatch Recently, in a column about five stocks that are struggling despite strong brands, I mentioned that I am believer in Twitter as an information filter but not as an investment.
Sign-up for UPDATE: Why you should dump your Twitter shares now investment picks
2014/7/25
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- Stock futures leaned lower Friday, as Amazon.com Inc. tumbled in premarket trade after disappointing results and Xerox Corp.
Sign-up for UPDATE: U.S. stocks: Nasdaq futures looks weak as Amazon tumbles investment picks
2014/7/25
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- German business confidence fell short of expectations Friday, weighing on German stocks as the report underscored worries that growth in Europe's largest economy is losing steam.
Sign-up for UPDATE: Euro, German stocks fall after downbeat IFO survey investment picks
Allergan, Inc. (NYSE: AGN) announced today that the European Union’s Committee for Medicinal Products for Human Use (CHMP) has recommended extending the Marketing Authorization for OZURDEX ® (dexamethasone 700 mcg intravitreal implant in applicator) to treat adult patients with vision loss due to diabetic macular edema (DME) who are pseudophakic (have an artificial lens implant), or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.
Sign-up for Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema investment picks
2014/7/25
http://media.marketwire.com/attachments/201104/24546_560807_MoogLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133276&ProfileId=051205&sourceType=1 EAST AURORA, NY --
Sign-up for Moog's Third Quarter Sales and EPS Higher investment picks
- Reports Second-Quarter Adjusted EPS of $0.82, Above Previous Guidance Range of $0.75 to $0.77 (Reports GAAP EPS of $0.68) - Delivers Second-Quarter Revenue of $4.926 Billion, an Increase of 5.0 Percent Over Second-Quarter 2013 (Up 4.8 Percent On an Operational Basis); Revenue Up 12.3 Percent Operationally Excluding Lipid Sales Due to Loss of Exclusivity - Revenue Growth Reflects 26.2 Percent Global Reported Sales Growth from HUMIRA (Up 25.4 Percent On an Operational Basis) and Strong Growth from Other Key Products - Pipeline Continues to Advance Including Phase 3 Start for ABT-888, Positive Phase 3 Data for Daclizumab, Priority Review (FDA) and Accelerated Assessment (EMA) of our HCV Program, Positive Data from Next-Generation HCV Program and ABT-414 for Glioblastoma - Continues to Enhance the Company's Position and Shape AbbVie for the Long-Term with Agreement to Merge with Shire, Creating a Larger and More Diversified Biopharmaceutical Company and Driving
Sign-up for AbbVie Reports Second-Quarter 2014 Financial Results investment picks
NEW YORK (MarketWatch) -- Shares of KLA-Tencor Corp.
Sign-up for KLA-Tencor sinks 6.5% premarket on profit miss investment picks
PLANO, Texas , July 1, 2014 /PRNewswire/ -- TGC Industries, Inc. (NASDAQ: TGE) today announced plans to release its second quarter 2014 financial results on Monday, July 28, 2014 before the market opens.
Sign-up for TGC Industries Announces Second Quarter 2014 Earnings Release and Conference Call Schedule investment picks
NEW YORK (MarketWatch) -- Gilead Sciences Inc. (GILD) said Friday that a key committee of the European Medicines Agency (EMA) is recommending that its Zydelig treatment for leukemia be approved for use in the 28 countries of the European Union.
Sign-up for Gilead says EU Committee to recommend approval of leukemia drug investment picks
Derma Sciences, Inc. (Nasdaq:DSCI) , a tissue regeneration company focused on advanced wound care, announces that Edward J.
Sign-up for Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of Shareholders investment picks
2014/7/25
Primoris Services Corporation (NASDAQ Global Select: PRIM) announced today that it will issue its financial results for the quarter ended June 30, 2014 on Thursday, August 7, 2014 before the opening of the stock market.
Sign-up for Primoris Services Corporation Schedules Release of 2014 Second Quarter Financial Results and Conference Call investment picks
CLEVELAND , July 25, 2014 /PRNewswire/ --TransDigm Group Incorporated (NYSE: TDG) today said it will report fiscal 2014 third quarter earnings before the market opens on Tuesday, August 5, 2014 .
Sign-up for TransDigm Third Quarter Earnings Report and Conference Call Set for Tuesday, August 5, 2014 investment picks
http://media.marketwire.com/attachments/201004/5466_capitalpartnersLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133226&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for Capital Product Partners L.P. Announces Second Quarter 2014 Financial Results and Charter Renewal for M/T 'Axios' investment picks
T-Mobile US, Inc. (NYSE:TMUS) will host a conference call to discuss its financial and operational results for the second quarter 2014 on Thursday, July 31, 2014 at 8:00 a.m. Eastern Daylight Time (EDT). T-Mobile US, Inc. will issue a press release reporting its results at approximately 6:00 a.m. EDT.
Sign-up for T-Mobile US, Inc. to Host Second Quarter 2014 Earnings Conference Call investment picks
Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Marketing Authorization Application (MAA) for Zydelig ® (idelalisib 150 mg film-coated tablets), a first-in-class treatment for patients with chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), the most common subtype of indolent non-Hodgkin lymphoma (iNHL). The CHMP opinion supports the use of Zydelig in combination with rituximab for the treatment of adult patients with CLL who have received at least one prior therapy or, as first-line treatment in CLL patients in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy and also as monotherapy for the treatment of adult patients with FL that is refractory to
Sign-up for European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma investment picks
Second Quarter Highlights: Earnings of $0.19 per diluted share Revenues increased 1.5% QOQ Noninterest income improved 5% QOQ driven by seasonal increases in various categories Net interest income stable as balance sheet growth was offset by margin compression Organic loan growth continues, with average loans up 7% annualized QOQ Average commercial business and real estate loans increased 8% QOQ Momentum in average indirect auto loans continues with $137 million increase Transactional deposits up 12% QOQ driven by higher customer balances and account acquisitions Noninterest-bearing and interest-bearing checking deposit balances increased 18% and 7% QOQ Transactional deposits averaged 36% of deposits, up from 34% a year-ago Strong credit quality maintained NCOs decreased six basis points QOQ to 0.30% of average originated loans BUFFALO, N.Y., July
Sign-up for First Niagara Reports Second Quarter 2014 Results investment picks
DETROIT , July 25, 2014 /PRNewswire/ -- DTE Energy (NYSE: DTE) today reported second quarter 2014 earnings of $124 million , or $0.70 per diluted share, compared with $105 million , or $0.60 per diluted share in 2013.
Sign-up for DTE Energy reports second quarter 2014 results investment picks
By MarketWatch Tobacco company Reynolds American Inc. (RAI) was hit with $23.6 billion in damages Friday after a Florida jury decided that the company acted negligently in marketing its tobacco products.
Sign-up for UPDATE: 10 countries where people smoke the most investment picks
Levi & Korsinsky is investigating the Board of Directors of QR Energy, LP (“QR Energy” or “the Company”) (NYSE:QRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Breitburn Energy Partners LP (Nasdaq:BBEP). Click here to learn more about the investigation: http://zlk.9nl.com/qr-energy-qre , or call: 877-363-5972.
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of QR Energy, LP and Its Board of Directors In Connection With the Sale of the Company to Breitburn Energy LP investment picks
NEW YORK (MarketWatch) -- Xerox Corp.
Sign-up for Xerox tops second-quarter profit estimates investment picks
Nexstar Broadcasting Group, Inc. (Nasdaq:NXST) announced today that its Board of Directors declared a quarterly cash dividend of $0.15 per share of its Class A common stock.
Sign-up for Nexstar Broadcasting Group Declares Quarterly Cash Dividend of $0.15 Per Share investment picks
2014/7/25
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- Stock futures leaned lower, with techs in particular setting up for a weak showing on Friday as Amazon.com Inc. began tumbling in premarket after posting disappointing results.
Sign-up for UPDATE: U.S. stocks: Nasdaq futures looks weak as Amazon tumbles investment picks
On July 14, 2014, the Board of Directors of Moody’s Corporation (NYSE: MCO) declared a regular quarterly dividend of 28 cents per share of MCO Common Stock.
Sign-up for Moody’s Corporation Declares Quarterly Dividend investment picks
Moody’s Corporation (NYSE:MCO) today announced results for the second quarter 2014.
Sign-up for Moody's Corporation Reports Results for Second Quarter 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: TCF Reports Quarterly Net Income of $53.1 Million, or 29 Cents Per Share, Up 8 Cents, or 38.1 Percent from the Second Quarter of 2013 to Moody's Corporation Reports Results for Second Quarter 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices